Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The RASSF1A tumor suppressor.

Howard Donninger1, Michele D Vos, Geoffrey J Clark

  • 1Molecular Targets Group, Department of Medicine, J. G. Brown Cancer Center, University of Louisville, 119C Baxter Boulevard, 580 S. Preston Street, Louisville, KY 40202, USA.

Journal of Cell Science
|September 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved prognostic survival models for pediatric medulloblastoma using high dimensional gene expression data.

BMC medical genomics·2026
Same author

RALGEF inhibitors suppress RAS-driven pancreatic cancer and metastasis.

The Journal of biological chemistry·2025
Same author

NORE1A loss promotes MASLD/MASH.

Transgenic research·2024
Same author

K-RAS Is…Complicated.

Cancers·2023
Same author

BRCA1 and NORE1A Form a Her2/Ras Regulated Tumor Suppressor Complex Modulating Senescence.

Cancers·2023
Same author

Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapy.

Science advances·2023
Same journal

FAM122A inhibition of PP2A-B55 through a bipartite binding mechanism.

Journal of cell science·2026
Same journal

Disentangling the response to lysosomal damage.

Journal of cell science·2026
Same journal

The force, form and function of the nucleus.

Journal of cell science·2026
Same journal

The nucleus-vacuole junction at a glance.

Journal of cell science·2026
Same journal

Loss of INPP5E affects photoreceptor outer segment membrane biogenesis in iPSC-derived human retinal organoids.

Journal of cell science·2026
Same journal

Brinker regulates reciprocal outcomes of BMP signal between stem cells and differentiating cells.

Journal of cell science·2026
See all related articles

Ras association domain family 1 isoform A (RASSF1A) is a tumor suppressor. Its inactivation, often via promoter methylation, contributes to cancer development by affecting cell cycle and apoptosis pathways.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Ras association domain family 1 isoform A (RASSF1A) is a tumor suppressor gene.
  • Inactivation of RASSF1A is linked to numerous human cancers.
  • Transcriptional silencing via promoter methylation is a key mechanism of RASSF1A inactivation.

Purpose of the Study:

  • To summarize the role of RASSF1A as a tumor suppressor.
  • To highlight the significance of epigenetic silencing in cancer development.
  • To discuss RASSF1A's function in apoptotic and cell cycle pathways.

Main Methods:

  • Literature review of RASSF1A function and cancer implications.
  • Analysis of epigenetic mechanisms, specifically promoter methylation.
  • Examination of RASSF1A's role in cell signaling pathways.

Related Experiment Videos

Main Results:

  • RASSF1A inactivation, primarily through methylation, is common in various cancers.
  • RASSF1A functions as a scaffold protein, integrating tumor suppressor complexes.
  • RASSF1A influences apoptosis and cell cycle checkpoints, potentially relaying signals from K-Ras.

Conclusions:

  • RASSF1A is a critical tumor suppressor frequently inactivated by epigenetic mechanisms.
  • Understanding RASSF1A's function is vital for cancer research and therapeutic strategies.
  • Epigenetic modifications represent a significant driver of tumorigenesis.